CLOs on the Move

Philips

www.philips.com

 
Royal Philips is a leading health technology company focused on improving people`s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Headquartered in the Netherlands, Philips`​ health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 69,000 employees with sales and services in more than 100 countries.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.philips.com
  • 4, 3000 Minuteman Rd
    Andover, MA USA 01810
  • Phone: 888.744.5477

Executives

Name Title Contact Details
Noel Denice
Legal Counsel Profile
Ernest Trello
Legal Counsel Profile
Michael Lapin
Senior Legal Counsel Profile
Jeff Burrow
Senior Legal Counsel Profile
Jonathan Kozusko
Legal Counsel Group Profile

Similar Companies

Companion Medical

Companion Medical is a leader in the development of advanced technology to improve diabetes care. Companion`s InPen system is available in the U.S. and is the only FDA-cleared, smart insulin pen paired with an integrated diabetes management app.

Cayenne Medical

Cayenne Medical is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

FORCE Therapeutics

FORCE Therapeutics is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Eppendorf

Eppendorf is a Enfield, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Proof Diagnostics

At Proof, we believe that knowledge is power—and good health is a necessity. We`re a health technology and diagnostics company that is currently developing a cutting-edge, CRISPR-based platform for point-of-care facilities to test for COVID-19, with ambitions to transform in-home diagnostics across a broad spectrum of health applications in the future. Proof is the brainchild of Professor Feng Zhang, a world-renowned molecular biologist and leader of a research lab at the Broad Institute of MIT and Harvard. In early 2020, Dr. Zhang along with Dr. Jonathan Gootenberg and Dr. Omar Abudayyeh of the McGovern Institute pivoted their focus towards combating the emergent threat of the COVID-19 pandemic. Pioneers of the CRISPR gene-editing technology, the three scientists dropped everything to face the global public health crisis head on. Combining CRISPR and RT-LAMP technologies in a novel approach, our scientific team is developing a simple, streamlined molecular diagnostics platform that can quickly test for the presence of the SARS-CoV-2 virus. Intended for use within clinics, pharmacies, schools, workplaces and eventually homes, our easy-to-use, lab-quality test platform is undergoing rigorous R&D protocols so that we can provide fast, accurate diagnostics that will help communities take control of their health. We want to transform the anxiety of waiting days for COVID-19 test results into the peace of mind of quickly knowing what steps to take next. Our first test system, which we`re designing to detect SARS-CoV-2, will enable us to fulfill our mission of helping restore a degree of normalcy to our world. From there, we aim to transform personalized health, and expand our diagnostic platform to detect other diseases, with the goal of providing actionable health information that will allow people to lead better, healthier lives. If you`re with us, reach out today.